Longitudinal study on prevalence, incidence and persistence of SARS-CoV-2 antibodies in health care workers using home blood collection kits and a fully automated ELISA and ECLIA antibody assay

Overview

Acronym
LSPIPSA-HCW
Investigators
Dr. Keith Jarvi
Mount Sinai Hospital
Contacts
Susan Lau
Mount Sinai Hospital

General Design

Study design
Cohort
Start - End Year
2020 - 2022
General Information on Follow Up (profile, frequency)
Recruitment Target
  • Individuals
Number of Participants
1,720
Number of Participants with Biological Samples
1,720
Supplementary information about number of participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

LSPIPSA-HCW - COVID-19 infected

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Territory
Toronto
Health Status

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LSPIPSA-HCW - COVID-19 infected - ELISA capillary blood samples
  • Biosamples
  • Blood
2020 (September) Ongoing
LSPIPSA-HCW - COVID-19 negative and untested

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Territory
Toronto
Health Status

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LSPIPSA-HCW - COVID-19 negative and untested - ELISA capillary blood samples
  • Biosamples
  • Blood
2020 (September) Ongoing
LSPIPSA-HCW - Longitudinal

Selection Criteria

Countries
  • Canada
Canadian Provinces
  • Ontario
Other Criteria

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information

Sample Size

Number of Participants
1,700
Number of Participants with Biological Samples
1,700

Data Collection Events

# Name Data sources Data sources - Biosamples Start End
0 LSPIPSA-HCW - Longitudinal - Blood collection
  • Questionnaires
  • Biosamples
  • Blood
2020 (September) Ongoing
1 LSPIPSA-HCW - Longitudinal - 3 months follow-up
  • Questionnaires
  • Biosamples
  • Blood
2020 (December) Ongoing
2 LSPIPSA-HCW - Longitudinal - 6 months follow-up
  • Questionnaires
  • Biosamples
  • Blood
2021 (March) Ongoing
3 LSPIPSA-HCW - Longitudinal - 12 months follow-up
  • Questionnaires
  • Biosamples
  • Blood
2021 (September) Ongoing
4 LSPIPSA-HCW - Longitudinal - 18 months follow-up
  • Questionnaires
  • Biosamples
  • Blood
2022 (March) 2022
5 LSPIPSA-HCW - Longitudinal - 1 month post-vaccination
  • Questionnaires
  • Biosamples
  • Blood
2021 (February) 2021

Participating Studies

Acronym Name Study design Countries

Harmonization Initiatives Included

Acronym Name

Datasets

Name Data Collection Events Variables

Areas of Information Collected

Socio-demographic and economic characteristics
Death
Lifestyle and behaviours
Physical measures and assessments
Birth, pregnancy and reproductive health history
Laboratory measures
Perception of health, quality of life, development and functional limitations
Cognition, personality and psychological measures and assessments
Diseases
Life events, life plans, beliefs and values
Symptoms and signs
Preschool, school and work life
Medication and supplements
Social environment and relationships
Non-pharmacological interventions
Physical environment
Health and community care services utilization
Administrative information

Variables Content Summary

Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected

Networks

Acronym Name Harmonization Initiatives Individual Studies
Last Update: 2024-02-27T14:39:38.857